Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

[Increased platelet-leukocyte aggregates in patients with acute coronary syndrome].

Yang DH, Tan N, He PC, Liu Y, Wen JY, Chen JY, Zhou YL, Huang WH.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jun;40(6):482-6. Chinese.

PMID:
22943642
3.

Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.

Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M.

Am Heart J. 2008 Jul;156(1):193-200. doi: 10.1016/j.ahj.2008.02.010. Epub 2008 Apr 23.

PMID:
18585516
4.

Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.

Brambilla M, Camera M, Colnago D, Marenzi G, De Metrio M, Giesen PL, Balduini A, Veglia F, Gertow K, Biglioli P, Tremoli E.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):947-53. doi: 10.1161/ATVBAHA.107.161471. Epub 2008 Feb 21.

5.

Correlations of platelet-leukocyte aggregates with P-selectin S290N and P-selectin glycoprotein ligand-1 M62I genetic polymorphisms in patients with acute ischemic stroke.

Tao L, Changfu W, Linyun L, Bing M, Xiaohui H.

J Neurol Sci. 2016 Aug 15;367:95-100. doi: 10.1016/j.jns.2016.05.046. Epub 2016 May 24.

PMID:
27423570
6.
7.

[Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes].

Lu HY, Chen D, Gu J, Song LX, Chen M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):678-83. doi: 10.7534/j.issn.1009-2137.2013.03.028. Chinese.

PMID:
23815921
8.

Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.

Czyz A, Kołacz E, Angerer D, Zawilska K.

Kardiol Pol. 2005 Mar;62(3):189-200; discussion 201. English, Polish.

PMID:
15830013
9.

Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.

Zhang YC, Wei JJ, Wang F, Chen MT, Zhang MZ.

Cell Biochem Biophys. 2012 Mar;62(2):365-72. doi: 10.1007/s12013-011-9295-0.

PMID:
21947962
10.

Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.

Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.

Indian Heart J. 2008 Nov-Dec;60(6):536-42.

PMID:
19276492
11.

[Relationship between antithrombin-III value with acute coronary syndrome and preprocedural TIMI flow grade].

Hong X, Shan PR, Hu L, Huang ZQ, Wu GJ, Xiao FY, Huang WJ.

Zhonghua Yi Xue Za Zhi. 2012 Mar 27;92(12):831-4. Chinese.

PMID:
22781457
12.

Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.

Stellos K, Bigalke B, Langer H, Geisler T, Schad A, Kögel A, Pfaff F, Stakos D, Seizer P, Müller I, Htun P, Lindemann S, Gawaz M.

Eur Heart J. 2009 Mar;30(5):584-93. doi: 10.1093/eurheartj/ehn566. Epub 2008 Dec 24.

PMID:
19109356
13.

Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome.

Gries A, Herr A, Kirsch S, Günther C, Weber S, Szabo G, Holzmann A, Böttiger BW, Martin E.

Crit Care Med. 2003 Jun;31(6):1697-704.

PMID:
12794407
14.

Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting.

Saygı S, Kırılmaz B, Tengiz İ, Türk UÖ, Yıldız H, Tuzun N, Alioğlu E, Tamer GS, Ercan E.

Turk Kardiyol Dern Ars. 2012 Apr;40(3):205-12. doi: 10.5543/tkda.2012.90083.

15.

Platelet aggregation at discharge: a useful tool in acute coronary syndromes?

Teixeira R, Monteiro P, Marques G, Pego JM, Lourenço M, Tavares C, Reboredo A, Monteiro S, Gonçalves F, Ferreira MJ, Freitas M, Ribeiro G, Providência LA.

Rev Port Cardiol. 2012 Sep;31(9):545-54. doi: 10.1016/j.repc.2012.06.005. Epub 2012 Aug 2.

PMID:
22857947
16.

Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count.

Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC.

Eur J Haematol. 2001 Mar;66(3):143-51.

PMID:
11350482
17.
18.

[Correlation of serum calprotectin level with the range of coronary lesion in patients with acute coronary syndrome].

Fang H, Xie N, Qin L, Xia K, Fang F, Yang T.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Sep;39(9):912-6. doi: 10.11817/j.issn.1672-7347.2014.09.008. Chinese.

19.

[Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].

Su JZ, Xue Y, Cai WQ, Huang QY, Chai DJ, Chen GL, Wang FB, Chen XP, Zhang DS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Sep;39(9):807-11. Chinese.

PMID:
22321227
20.

Clinical significance of detection of carotid artery plaque in patients with acute coronary syndrome.

Liu JL, Guan LJ, Chen L, Hao BS.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Feb;24(2):204-6.

Supplemental Content

Support Center